Bicara Therapeutics BCAX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's operating lease ROU assets?
- Bicara Therapeutics (BCAX) reported operating lease ROU assets of $1.43M in Q1 2026.
- How has Bicara Therapeutics's operating lease ROU assets changed year-over-year?
- Bicara Therapeutics's operating lease ROU assets increased by 158.7% year-over-year, from $552K to $1.43M.
- What is the long-term trend for Bicara Therapeutics's operating lease ROU assets?
- Over 2 years (2023 to 2025), Bicara Therapeutics's operating lease ROU assets has grown at a 66.6% compound annual growth rate (CAGR), from $613K to $1.7M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.